China Shineway Pharmaceutical Group Limited CSWYF의 지난 분기 매출 실적은 어땠나요?
China Shineway Pharmaceutical Group Limited의 매출 추정치는 얼마인가요?
China Shineway Pharmaceutical Group Limited의 수익 품질 점수는 얼마인가요?
China Shineway Pharmaceutical Group Limited는 언제 수익을 보고하나요?
China Shineway Pharmaceutical Group Limited의 예상 수익은 얼마인가요?
China Shineway Pharmaceutical Group Limited은 수익 기대치를 충족했나요?
주요 통계
이전 종가
$1
시가
$1
일일 범위
$0.9253 - $1
52주 범위
$0.9253 - $1
거래량
100
평균 거래량
0
EPS(TTM)
0.21
배당수익률
--
시가총액
$758.4M
CHINA SHINEWAY PHARMACEUTICAL G란 무엇인가요?
China Shineway Pharmaceutical Group Ltd. is an investment holding company, which engages in the research and development, manufacturing, and trading of Chinese pharmaceutical products. The company is headquartered in Shijiazhuang, Hebei and currently employs 2,867 full-time employees. The company went IPO on 2004-12-02. The Company’s product dosage forms include injections, soft capsules, granules, traditional Chinese medicine (TCM) granules, oral products and other dosage forms. The Company’s products include Qing Kai Ling Injection, Shen Mai Injection, Wu Fu Xin Nao Qing Soft Capsule, Qing Kai Ling Soft Capsule, Huamoyan Granule, Compound Licorice Tablet and other products, applied to influenza, cardio-cerebrovascular, respiratory system and other disease fields. The firm operates its business in mainland China and Hong Kong markets.